3Groenink M,Barbara JM.Severe cardiovascular features of Marfan syndrome in childhood:Just another manifestation or a specific entity[J]?Inter J Cardiovas Imag,2004,20:269-270.
4Meijboom LJ,Timmermans J.Evaluation of left ventricular dimensions and function in Marfan′s syndrome without significant valvular regurgitation[J].Am J Cardiol,2005,95:795-797.
5Rios AS,Silber EN,Bavishi N,et al.Effect of long-term beta-blockade on aortic root compliance in patients with Marfan′s syndrome[J].Am Heart J,1999,137:1057-1061.
6Yetman AT,Bornemeier RA.Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the marfan syndrome[J].Am J Cardiol,2005,95:1125-1127.
7Pyeritz RE,McKusick VA.The Marfan syndrome:Diagnosis and management[J].N Engl J Med,1979,300(14):772.
8de Paepe A,Devereux RB,Dietz HC,et al.Revised diagnostic criteria for the Marfan syndrome[J].Am J Med Genet,1996,62:417-426.
9Baumgartner D,Baumgartner C.Diagnostic power of aortic elastic properties in young patients with Marfan syndrome[J].J Thoracic Cardiovas Surg,2005,4:730-739.
10Osterhof 7,Nollen GJ,van der Wall EE,et al.Comparison of aortic stiffness in patients with juvenile forms of ascending aortic dilatation with versus without Marfan′s syndrome[J].Am J Cardiol,2005,95:996-998.
